News Category
Creative Biolabs is promoting its tumor organoid and immune cell co-culture services, including CAR-T models, to provide more physiologically relevant...
Creative Biolabs has launched an integrated OMV and exosome-boosted CAR-T development platform to help researchers address the key barriers limiting C...
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies to cut animal use and speed up development of its antibody-based cancer therapie...
Lantern Pharma receives Taiwan regulatory and IRB approvals to open Part 2 of its Phase 2 HARMONIC trial of LP-300, potentially accelerating developme...
VERAXA Biotech's adoption of FDA-aligned New Approach Methodologies could significantly reduce animal testing and accelerate the development of its ne...
New research reveals lymph node-like structures in the skull's bone marrow that could mobilize immune responses against brain diseases, opening doors ...
A blood-based method for identifying cancer-specific proteins could replace the need for surgical tumor biopsies, potentially accelerating the develop...
GeoVax's next-generation MVA-X vaccine demonstrated durable single-dose protection against lethal Clade I mpox and other orthopoxviruses in preclinica...
Onco-Innovations is integrating manufacturing, preclinical and regulatory activities for its lead cancer candidate ONC010, aiming to advance it toward...
Incorporating clinical trial discussions into the initial appointment for small cell lung cancer can provide patients with timely access to emerging t...
Telomir Pharmaceuticals' Telomir-Zn demonstrated growth inhibition in human and canine osteosarcoma cell lines, supporting further studies that could ...
Dr. Wael Sakr has announced a one-time $1,000 scholarship for undergraduate pre-med students across the United States, aiming to ease financial burden...
Creative Biolabs has expanded its single-cell multi-omics and RNA sequencing services, offering high-resolution tools that overcome long-standing samp...
A comprehensive review reveals that the tumor microenvironment actively reprograms natural killer cells into distinct subsets with specialized functio...
The September 17 Life Sciences Virtual Investor Forum will feature seven companies presenting live across high-impact therapeutic areas, providing inv...
VERAXA Biotech's appointment of Dr. Christoph Erkel as chief scientific officer strengthens its leadership as it advances its BiTAC® T-cell engager an...
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial for multiple sclerosis, potentially...
Onco-Innovations' CMO detailed the company's novel PNKP-targeting drug candidate ONC010, which uses synthetic lethality and nanoparticle delivery to p...
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial in multiple sclerosis,...
Kairos Pharma's CEO presentation at a major investment conference underscores the company's progress in developing ENV-105, an antibody aimed at rever...
GeoVax applauds the new global mpox vaccine stockpile and highlights its GEO-MVA candidate's readiness to support a diversified supply.
VERAXA Biotech's appointment of Raju Willener as CFO signals a strategic move to enhance its capital strategy and support the advancement of its oncol...
Onco-Innovations Ltd. strengthens its clinical foundation for ONC010, a nanoparticle-encapsulated PNKP inhibitor, through manufacturing milestones, IN...
OS Animal Health's presentation at the Moody Capital conference underscores its strategic push to secure USDA conditional approval for OST-HER2, a pro...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS, a first-in-class myelin repair candidate, marks a pivotal step toward treating the ...
A new study from Washington University School of Medicine highlights the growing role of laser interstitial thermal therapy (LITT) in treating brain c...
Quantum BioPharma's FDA clearance for a phase 2 trial of Lucid-MS marks a potential breakthrough in treating multiple sclerosis by targeting myelin re...
NanoViricides' registration of its Phase II Ebola trial in the DRC marks a critical step in evaluating NV-387 as a potential treatment for Ebola, with...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS, a novel remyelination agent, marks a significant step in MS treatment and draws ana...
Amid historic lows in youth tobacco use, the FDA's authorization of ZYN nicotine pouches with reduced-risk claims offers adult smokers a scientificall...
A large study reveals that the timing of brain metastasis development significantly impacts survival in colorectal cancer patients, underscoring the n...
Onco-Innovations has achieved significant preclinical milestones for its PNKP inhibitor ONC010, including high-purity API production and an Australian...
VERAXA Biotech's appointment of Raju Willener as CFO underscores its commitment to advancing its BiTAC technology and oncology pipeline through strate...
OS Therapies' participation at the Moody Capital conference comes as it approaches key FDA and U.K. regulatory decisions and data readouts for its lea...
A Swiss-led preclinical study reveals that administering immunotherapy prior to surgical resection significantly improves glioblastoma treatment outco...
New research from Mass General Brigham reveals that unintended radiation to the thymus during lung cancer treatment is associated with poorer clinical...
Salman Fazal, MD, a hematologist and stem cell transplant expert at UPMC Hillman Cancer Center, has been named a 2026 Castle Connolly Top Doctor for t...
NanoViricides is progressing its measles treatment NV-387 to Phase II clinical trials, leveraging FDA designations and strong preclinical data as meas...
TransCode Therapeutics announced peer-reviewed preclinical results showing its lead candidate TTX-MC138 accumulates in metastatic bone lesions, inhibi...
A nurse's personal battle with metastatic triple-negative breast cancer underscores the significance of emerging ADC therapies and the need for inform...
This article explains the importance of PSMA testing for prostate cancer patients, featuring insights from Dr. Phillip Koo and patient advocate Bill, ...
The NMPA has cleared a Phase Ib/II trial in China for Heidelberg Pharma's BCMA-targeting ADC HDP-101 in combination therapies for relapsed/refractory ...
A new study published in Critical Care Medicine demonstrates that VolitionRx's Nu.Q NETs H3.1 biomarker independently predicts 28-day mortality and re...
Novogenia's U.S. launch of the MGT Plus methylation test marks a significant expansion in genetic testing capabilities, offering a more comprehensive ...
Citius Pharmaceuticals is transitioning to a commercial-stage biopharma with LYMPHIR's launch and a robust pipeline, signaling significant potential f...
Annovis Bio announces a corporate update webinar to discuss its Phase 3 Alzheimer's trial and upcoming milestones, highlighting the potential of bunta...
A new study suggests that a personalized mRNA vaccine derived from a patient's tumor can prevent melanoma recurrence for years, highlighting the poten...
Creative Biolabs announces a webinar featuring Dr. Greg M. Delgoffe to discuss modeling T cell dysfunction in the tumor microenvironment, highlighting...
